Thursday 26th May 2022
A British man has become the first Scleroderma patient to receive a double hand transplant for the condition, giving him a new lease of life and prompting hope for many of those most severely affected by the condition.
Tuesday 10th May 2022
New research suggests the ‘VEDOSS’ Criteria could be used to accurately predict which individuals living with Raynaud's are likely to progress to Systemic Sclerosis, prompting further hope regarding the early detection and treatment of the condition.
Friday 22nd April 2022
SRUK co-funds a MRC Clinical Research Training Fellowship to advance research into treatments for interstitial lung disease.
Wednesday 20th April 2022
Ongoing research towards developing new treatments and therapies has a cumulative effect in improving quality of life, but can the problem be addressed directly?
Friday 25th March 2022
On the 17th March 2022 the UK’s Medicine and Health products Regulation Agency (MHRA) approved a new drug, Evusheld, for the prevention of COVID-19 infection.
Thursday 10th March 2022
Can you imagine a future where we will be able to eliminate trial and error in prescribing medications by predicting the best treatment for a person’s scleroderma before they even receive it! The winning proposal of the SRUK/ WSF Stratified Medicine of the Future Award aspires to make this a reality.
Friday 25th February 2022
Happy Raynaud's Awareness Month! In this week's article we take a closer look at some of the upcoming research focused on Raynaud's!
Thursday 17th February 2022
Friday 11th February 2022
A national trial is recruiting people with scleroderma to see how they have responded to their COVID-19 vaccinations. Have they produced antibodies?
Friday 4th February 2022
STAR is the newly upgraded app for tracking your Raynaud’ symptoms. The App was created to help you manage and record your attacks, all whilst contributing to valuable scientific research in just a few simple clicks.
